CPSC to Consider Proposed Rule on Certain OTC Child-Resistant Packaging
The Consumer Product Safety Commission has posted a briefing package and a draft proposed rule that would require child-resistant packaging for any over-the-counter or prescription drug product containing the equivalent of 0.08 milligrams or more of an imidazoline (tetrahydrozoline, naphazoline,…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
oxymetazoline, and xylometazoline) in a single package. Imidazolines are a family of drugs that are vasoconstrictors indicated for nasal congestion and/or ophthalmic irritation. The Commission is scheduled to vote on the draft proposed rule by January 18, 2012.